SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-18-004078
Filing Date
2018-04-05
Accepted
2018-04-05 08:20:02
Documents
2
Period of Report
2018-03-26
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT f8k032618b_immudyneinc.htm 8-K 29271
2 PURPUREX LICENSE AGREEMENT BY AND BETWEEN IMMUDYNE, PR, LLC AND M.ALPHABET, LLC, f8k032618bex10-1_immudyne.htm EX-10.1 131713
  Complete submission text file 0001213900-18-004078.txt   162150
Mailing Address 1460 BROADWAY NEW YORK NY 10036
Business Address 1460 BROADWAY NEW YORK NY 10036 914-244-1777
Immudyne, Inc. (Filer) CIK: 0000948320 (see all company filings)

IRS No.: 760238453 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55857 | Film No.: 18739355
SIC: 2833 Medicinal Chemicals & Botanical Products